Document is current
Any future updates will be listed below
-
Authors
Mwizerwa, Oscar
Knight, Andrea M.
Dominguez, Daniela
Levy, Deborah
Convery, Holly
Thompson, Kendal
Gold, Nicholas
Walsh, Catharine M.
Hiraki, Linda T.
- License Information
-
More Information
Article History
Received: 27 February 2025
Revised: 11 August 2025
Accepted: 24 August 2025
First Online: 15 October 2025
Ethical approval
: This study was approved by the institution Research Ethics Board (REB number: 1000079489). As participants were enrolled in other studies (i.e. either Lupus Biorepository and/or The 1000 Canadian Faces of Lupus Studies), a waiver of consent has been approved by Hospital REB for the chart review of the larger cohort. Consent was obtained only from participants with biopsy-confirmed CeD and who were still active patients in the Lupus clinic.
: The authors declare no competing interests. L.T.H. holds a Canada Research Chair (Tier 2) in Genetics of Rare Systemic Inflammatory Diseases, and research is supported by Childhood Arthritis and Rheumatology Research Alliance (CARRA), Lupus Research Alliance (LRA), U.S. Department of Defense, Lupus Foundation of America, Gary Hurvitz Centre for Brain & Mental Health Catalyst Grant. A.M.K. is supported by a Canada Research Chair (Tier 2) in Mental Health and Chronic Disease of Childhood, and Lupus Research Alliance Career Development Award.
